United States· US:58411-482_47a942d9-4873-7a93-e063-6394a90abf65
SHISEIDO FUTURE solution LX UNIVERSAL DEFENSE E
A medicinal product containing octisalate; octocrylene; zinc oxide, registered in United States by SHISEIDO AMERICAS CORPORATION.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTISALATE; OCTOCRYLENE; ZINC OXIDE
- Manufacturer
- SHISEIDO AMERICAS CORPORATION
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1158411482601 TUBE in 1 CARTON (58411-482-60) / 50 mL in 1 TUBE
- ndc1158411-482-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c7783e39-ee98-4253-a308-53d9194bdd79 GET /v1/drugs/c7783e39-ee98-4253-a308-53d9194bdd79?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "2.523; 3.532; 7.723",
"substance": "OCTISALATE; OCTOCRYLENE; ZINC OXIDE",
"productndc": "58411-482",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/50mL; g/50mL; g/50mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octisalate; octocrylene; zinc oxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.